Eton Pharmaceuticals Financials

Values in thousands	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Revenue	$37,589	$24,266	$21,281	$22,459
Gross Profit	25,413	14,735	13,100	7,855
EBITDA	12,794	1,865	3,638	265
EBIT		734	2,622	-743
Net Income	11,578	1,554	1,483	-1,927
Net Change In Cash	37,589	24,266	21,281	22,459
Free Cash Flow	7,260	7,330	-11,600	11,742
Cash	26,845	19,661	25,942	37,121
Basic Shares	32,787	31,547	26,908	26,893

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$79,950	$39,011	$31,642	$21,251
Gross Profit	42,740	23,411	21,061	14,318
EBITDA	4,266	-657	212	-7,247
EBIT	223	-1,803	-689	-9,021
Net Income	-4,601	-3,823	-936	-9,021
Net Change In Cash	79,950	39,011	31,642	21,251
Cost of Revenue				1,899
Free Cash Flow	10,191	943	6,040	2,033
Cash	25,942	14,936	21,388	16,305
Basic Shares	26,908	25,895	25,645	25,146